Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Vote in favor of the Web-based Work out schedule to Keep You Fit and Sound - 2Israel intensifies Lebanon attacks and hits areas not in Hezbollah's control
- 3A Pompeii site reveals the recipe for Roman concrete. It contradicts a famous architect’s writings
- 4Nestlé recalls infant formula in 49 countries. See list.
- 5Home Machine Basics: An Exhaustive Purchasing Guide
- Smoking rate among US adults drops to record low as vape use rises, CDC report finds
- Map shows more than 1,900 measles cases across U.S.
- Make your choice for the bird that catches your heart!
- How did Hugh Jackman nail his latest role? Sequins, tighty-whities and embracing 'zero embarrassment.'
- Russia confirms 16 Cameroonian soldiers killed in Ukraine war
- Hezbollah field commander killed in IDF strikes in Beirut
- Pfizer in $41.5 million settlement with Texas over ADHD drug for children
- David Duchovny's new thriller has him stripping down at 65. But its chilling premise hits close to home.
- The Iconic, Instantly Recognizable Plastic Chair That's Known All Around The World
